NASDAQ:ELGX - Endologix Stock Price, Forecast & News

Endologix trades on the NASDAQ under the ticker symbol "ELGX."

Shares of Endologix reverse split on the morning of Wednesday, March 6th 2019. The 1-10 reverse split was announced on Tuesday, March 5th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, March 5th 2019. An investor that had 100 shares of Endologix stock prior to the reverse split would have 10 shares after the split.

Endologix, Inc. (NASDAQ:ELGX) posted its quarterly earnings data on Wednesday, November, 6th. The medical instruments supplier reported ($0.55) EPS for the quarter, topping the Zacks' consensus estimate of ($0.63) by $0.08. The medical instruments supplier earned $35.78 million during the quarter, compared to the consensus estimate of $35.26 million. Endologix had a negative return on equity of 99.62% and a negative net margin of 58.24%. View Endologix's Earnings History.

Endologix is scheduled to release their next quarterly earnings announcement on Monday, February 24th 2020. View Earnings Estimates for Endologix.

3 brokers have issued 1 year target prices for Endologix's stock. Their forecasts range from $7.00 to $7.00. On average, they expect Endologix's share price to reach $7.00 in the next twelve months. This suggests a possible upside of 351.6% from the stock's current price. View Analyst Price Targets for Endologix.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Endologix in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Endologix.

News coverage about ELGX stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Endologix earned a news impact score of -1.4 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Endologix.

Endologix saw a decrease in short interest during the month of December. As of December 13th, there was short interest totalling 655,300 shares, a decrease of 5.8% from the November 28th total of 695,400 shares. Based on an average trading volume of 163,900 shares, the days-to-cover ratio is currently 4.0 days. Currently, 4.3% of the shares of the company are sold short. View Endologix's Current Options Chain.

Some companies that are related to Endologix include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Antares Pharma (ATRS), Cerus (CERS), Anika Therapeutics (ANIK) and OraSure Technologies (OSUR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Endologix investors own include CA (CA), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Och-Ziff Capital Management Group (OZM), Gran Tierra Energy (GTE), Belden (BDC) and Precision Drilling (PD).

Shares of ELGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ELGX stock can currently be purchased for approximately $1.55.

Endologix has a market capitalization of $27.81 million and generates $156.47 million in revenue each year. The medical instruments supplier earns $-79,710,000.00 in net income (profit) each year or ($7.20) on an earnings per share basis. Endologix employs 528 workers across the globe.View Additional Information About Endologix.

The official website for Endologix is http://www.endologix.com/.

Endologix's mailing address is 2 MUSICK, IRVINE CA, 92618. The medical instruments supplier can be reached via phone at 949-595-7200 or via email at [email protected]